Document is current
Any future updates will be listed below
-
Authors
Allison, Kelly C. https://orcid.org/0000-0002-9807-0220
Wu, Jingwei
Spitzer, Jacqueline C.
McCuen-Wurst, Courtney
Ashare, Rebecca L.
Tewksbury, Colleen
LaGrotte, Caitlin A.
Wadden, Thomas A.
Williams, Noel N.
Sarwer, David B.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK108628)
Pennsylvania Department of Health (FY2015 Pennsylvania Commonwealth Universal Research Enhancement Program Formula Funding (PA CURE))
- License Information
-
More Information
Article History
Received: 28 July 2022
Revised: 22 December 2022
Accepted: 27 December 2022
First Online: 24 January 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Rebecca L. Ashare has an investigator-initiated grant from Novo Nordisk, Inc., for a study unrelated to current paper. Thomas A. Wadden reports serving on advisory boards for Novo Nordisk and WW International Co. and receiving grants from Novo Nordisk and Epitomee Medical Ltd. David B. Sarwer reports grants from FY2015 Pennsylvania Commonwealth Universal Research Enhancement Program Formula Funding (PA CURE); grants from National Institute of Dental and Craniofacial Research, during the conduct of the study; personal fees from Ethicon; and personal fees from Novo Nordisk, Inc., outside the submitted work. All other authors declare no competing interests.
